1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. INHALATION DRUG DELIVERY MARKET BY TECHNOLOGY
5.1. Dry powder inhaler
5.2. Metered dose inhaler
5.3. Nebulizer
5.4. Liquid inhaler
6. INHALATION DRUG DELIVERY MARKET BY APPLICATION
6.1. Disease Treatment
6.2. Research/Academic Purposes
7. INHALATION DRUG DELIVERY MARKET BY GEOGRAPHY
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. United Kingdom
7.3.2. Germany
7.3.3. France
7.3.4. Others
7.4. Middle East and Africa
7.4.1. Saudi Arabia
7.4.2. UAE
7.4.3. Israel
7.4.4. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. India
7.5.3. Australia
7.5.4. South Korea
7.5.5. Others
8. COMPETITIVE INTELLIGENCE
8.1. Company Benchmarking and Analysis
8.2. Recent Investment and Deals
8.3. Strategies of Key Players
9. COMPANY PROFILES
9.1. GlaxoSmithKline group of companies
9.2. Merck & Co., Inc.
9.3. AstraZeneca
9.4. Boehringer Ingelheim International GmbH
9.5. Gerresheimer AG
9.6. Medisol Lifescience Pvt. Ltd
9.7. Cipla Limited
9.8. H&T Presspart Manufacturing Ltd.
LIST OF FIGURES
LIST OF TABLES